InsidersTradesSigma
Follow the CBL stock price and the full insider trade history of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Healthcare & Pharma sector, CBL has logged 6 insider filings. Market capitalisation: €1.7bn. The latest transaction was disclosed on 1 September 2026 (Purchase). Among the most active insiders: Phoenix Development Fund Limited. Every trade is openly available.
6
Insider Decl.
n/a
Thresholds
€6,426
1 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CBL Strong Buy (bullish), based on 2 analysts. Average price target: US$63.00.
Fundamental score
Ranked 2,079 of 29,062 companies
76.7
score / 100
Value81
Quality73
FCF yld15%
Earn yld7.9%
EV/EBITDA7.9x
ROE62%
Gross mgn65%
Net mgn23%
Debt/EBITDA4.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 September 2026
Declarations6 total
169,210 shares@ A$0.0615ShareASXASX:2924-03130181-2A1694210
ShareASXASX:2924-03107639-2A1682246
ShareASXASX:2924-03090203-2A1672120
ShareASXASX:2924-03090202-2A1672119
6 of 6 declarations
关于 CBL
CBL 是一家在 XASX 市场上市的健康和制药行业的公司。它专注于开发和商业化创新解决方案以改善医疗保健。
